Title : A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral antidiabetic drugs: The merit study.

Pub. Date : 2018 Dec

PMID : 29961975






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Mean (+-standard deviation) change in HbA1c from baseline to endpoint was -1.74 +- 1.64% and -1.32 +- 2.05% with BIAsp 30 plus metformin and BIAsp 30, respectively. Metformin hemoglobin subunit alpha 1 Homo sapiens